Compare Nuvation Bio Inc. Class A Common Stock (NUVB) vs Virgin Galactic Holdings, Inc. (SPCE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuvation Bio Inc. Class A Common Stock vs Virgin Galactic Holdings, Inc. — how do they compare? Nuvation Bio Inc. Class A Common Stock trades at $4.95 (market cap $1.71B), while Virgin Galactic Holdings, Inc. trades at $2.94 (market cap $456.30M). The key difference: Nuvation Bio Inc. Class A Common Stock is far larger — about 3.7× Virgin Galactic Holdings, Inc.'s market cap, and Nuvation Bio Inc. Class A Common Stock is trading nearer its 52-week high, Virgin Galactic Holdings, Inc. nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Nuvation Bio Inc. Class A Common Stock for 0 Days and Virgin Galactic Holdings, Inc. for 69 Days on average.
| NUVB | SPCE | |
|---|---|---|
Market Cap | $1.71B | $456.30M |
Volume | 5,448,712 | 4,518,834 |
Sector | Health | Industrials |
52-Week High | $9.54 | $7.52 |
52-Week Low | $3.41 | $2.17 |
Typical Hold Time | 0 Days | 69 Days |
Enterprise Value | $1.30B | $420.29M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
SPCE trades at $2.94, down 4.23% today, reflecting a bearish technical outlook amid persistent fundamental challenges. The company continues to report significant losses, with a net income margin of -23,867.44% in 2025, though recent quarters have seen earnings beats. Cash flow remains negative, but trends show improvement, with a projected positive net cash flow of $25M in 2026. Analyst sentiment is mixed, with a Buy/Hold/Sell split of 29%/41%/29%.
The outlook remains high-risk due to ongoing cash burn and delayed commercial flights, but strong ticket demand and a path to positive cash flow by 2027 offer long-term potential. Investors face substantial volatility and dilution risks, requiring careful risk management.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Nuvation Bio Inc. Class A Common Stock
Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →About Virgin Galactic Holdings, Inc.
Virgin Galactic Holdings Inc. develops space vehicles. The Company designs exploration technology such as missiles, rockets, and other related equipment. Virgin Galactic Holdings serves customers in the United States.
Read more on SPCE →
